您使用提示模式 关闭

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
 
(%)
US78464A8707
XBI ISIN
交易所交易基金 (ETF)
基金类型
SPDR State Street Global Advisors
提供商
133,78 USD
每股资产净值 | 2026-06-12
2006-01-31
成立日期
4 每年的次数
股息的支付
CEOILS
CFI
XBI
代码
Formed
Status
Equity
投资项目
Biotech
部门
USA
地区分布
S&P Biotechnology Select Industry Index
基准
0.35 %
总成本比率
8.297,62 百万 USD
基金资产总量 | 2026-06-12
8.297,62 百万 USD
股票类资产 | 2026-06-12
否
UCITS
1 / 3 (11/09/2015)
拆分

收益率 在 2026-06-12, NYSE Arca

  • YTD
    5,06 %
  • 1M
    -7,93 %
  • 3M
    1,65 %
  • 6M
    11,2 %
  • 1Y
    62,15 %
  • 3Y
    51,47 %
  • 5Y
    0,91 %
  • 10Y
    143,19 %
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (XBI)

探索最全面的数据库

1 000 000

债券

80 234

股票

167 970

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

结构 XBI 在 2026-06-11

下载结构至 Excel 文档
证券 值
TG THERAPEUTICS INC 1,99%
TRAVERE THERAPEUTICS INC 1,92%
ALKERMES PLC 1,88%
TWIST BIOSCIENCE CORP 1,84%
REVOLUTION MEDICINES INC 1,74%
EXELIXIS INC 1,49%
ARROWHEAD PHARMACEUTICALS IN 1,49%
KRYSTAL BIOTECH INC 1,47%
NEUROCRINE BIOSCIENCES INC 1,46%
NUVALENT INC A 1,44%
APOGEE THERAPEUTICS INC 1,39%
INCYTE CORP 1,32%
PROTAGONIST THERAPEUTICS INC 1,32%
PTC THERAPEUTICS INC 1,32%
BEAM THERAPEUTICS INC 1,31%
NATERA INC 1,3%
MADRIGAL PHARMACEUTICALS INC 1,28%
VERACYTE INC 1,27%
CYTOKINETICS INC 1,27%
MIRUM PHARMACEUTICALS INC 1,26%
HALOZYME THERAPEUTICS INC 1,24%
BIOGEN INC 1,22%
SCHOLAR ROCK HOLDING CORP 1,2%
SPYRE THERAPEUTICS INC 1,19%
KYMERA THERAPEUTICS INC 1,18%
CRISPR THERAPEUTICS AG 1,17%
ROIVANT SCIENCES LTD 1,17%
UNITED THERAPEUTICS CORP 1,16%
ARCUTIS BIOTHERAPEUTICS INC 1,16%
IMMUNOVANT INC 1,16%
ABBVIE INC 1,15%
IONIS PHARMACEUTICALS INC 1,15%
RHYTHM PHARMACEUTICALS INC 1,13%
BRIDGEBIO PHARMA INC 1,1%
AMGEN INC 1,09%
BIOMARIN PHARMACEUTICAL INC 1,07%
COGENT BIOSCIENCES INC 1,05%
VERTEX PHARMACEUTICALS INC 1,05%
ALNYLAM PHARMACEUTICALS INC 1,05%
MODERNA INC 1,03%
ULTRAGENYX PHARMACEUTICAL IN 1,02%
IMMUNITYBIO INC 1,01%
CG ONCOLOGY INC 1,01%
GILEAD SCIENCES INC 1%
ACADIA PHARMACEUTICALS INC 1%
CATALYST PHARMACEUTICALS INC 0,98%
PRAXIS PRECISION MEDICINES I 0,97%
VAXCYTE INC 0,96%
DISC MEDICINE INC 0,95%
VIKING THERAPEUTICS INC 0,93%
REGENERON PHARMACEUTICALS 0,92%
ERASCA INC 0,91%
CELCUITY INC 0,9%
VERA THERAPEUTICS INC 0,88%
SUMMIT THERAPEUTICS INC 0,87%
GRAIL INC 0,86%
DYNE THERAPEUTICS INC 0,85%
DENALI THERAPEUTICS INC 0,82%
TANGO THERAPEUTICS INC 0,81%
INSMED INC 0,81%
BIOCRYST PHARMACEUTICALS INC 0,78%
AGIOS PHARMACEUTICALS INC 0,76%
IMMUNOME INC 0,74%
RECURSION PHARMACEUTICALS A 0,72%
ORUKA THERAPEUTICS INC 0,72%
ARCUS BIOSCIENCES INC 0,69%
NURIX THERAPEUTICS INC 0,65%
IDEAYA BIOSCIENCES INC 0,64%
INTELLIA THERAPEUTICS INC 0,64%
SAREPTA THERAPEUTICS INC 0,63%
KODIAK SCIENCES INC 0,63%
UNIQURE NV 0,62%
DIANTHUS THERAPEUTICS INC 0,62%
ARDELYX INC 0,61%
BIOHAVEN LTD 0,6%
VIRIDIAN THERAPEUTICS INC 0,59%
VERICEL CORP 0,59%
MINERALYS THERAPEUTICS INC 0,58%
NOVAVAX INC 0,58%
SYNDAX PHARMACEUTICALS INC 0,58%
MANNKIND CORP 0,56%
ADMA BIOLOGICS INC 0,56%
RELAY THERAPEUTICS INC 0,55%
CELLDEX THERAPEUTICS INC 0,5%
SELLAS LIFE SCIENCES GROUP I 0,5%
CAREDX INC 0,48%
MONTE ROSA THERAPEUTICS INC 0,46%
STOKE THERAPEUTICS INC 0,45%
IOVANCE BIOTHERAPEUTICS INC 0,44%
TAYSHA GENE THERAPIES INC 0,43%
ABSCI CORP 0,4%
CAPRICOR THERAPEUTICS INC 0,4%
PALVELLA THERAPEUTICS INC 0,4%
ANAPTYSBIO INC 0,38%
INHIBRX BIOSCIENCES INC 0,38%
PRECIGEN INC 0,37%
CORVUS PHARMACEUTICALS INC 0,34%
OLEMA PHARMACEUTICALS INC 0,33%
RIGEL PHARMACEUTICALS INC 0,31%
KURA ONCOLOGY INC 0,31%
显示所有 隐藏
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权